Dr Su Han Lum
Dr Geoff Shenton
Professor Sophie Hambleton
Professor Andrew Gennery
Professor Mary Slatter
et al. | Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts | 2024 |
|
Dr Su Han Lum
Dr Alexandra Laberko
Professor Andrew Gennery
Professor Mary Slatter
| Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity | 2024 |
|
Dr Su Han Lum
| Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party | 2023 |
|
Dr Su Han Lum
Dr Zohreh Nademi
Dr Terence Flood
Professor Timothy Cheetham
Dr Mario Abinun
et al. | Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency | 2021 |
|
